Evofem Biosciences, Inc. revenue for the last year amounted to 18.22 M USD, the most of which — 18.22 M USD — came from its highest performing source at the moment, Women Sexual and Reproductive Health, the year earlier bringing 16.84 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Evofem Biosciences, Inc. 18.22 M USD, and the year before that — 16.84 M USD.